Boardroom Alpha
Start trial
8-K primary document
MDCX · Current Report (Form 8-K) · Filed April 24, 2026

Medicus Pharma Ltd — 8-K exhibit

exhibit10-1.htm
Medicus Pharma Ltd on Boardroom Alpha
Medicus Pharma Ltd.: Exhibit 10.1 - Filed by newsfilecorp.com

MEDICUS PHARMA LTD.

Up to $50,000,000 of Common Shares

AMENDMENT NO. 1 TO EQUITY DISTRIBUTION AGREEMENT

April 23, 2026

Maxim Group LLC
300 Park Avenue, 16th Floor
New York, New York 10022

Yorkville Securities, LLC
1012 Springfield Avenue
Mountainside, NJ 07092

Ladies and Gentlemen:

Reference is made to that certain Equity Distribution Agreement, dated as of December 29, 2025 (the "Agreement"), by and among Medicus Pharma Ltd., a corporation organized under the laws of Ontario, Canada (the "Company"), and Maxim Group LLC and Yorkville Securities, LLC, as sales agents (the "Agents"). Capitalized terms used but not defined in this letter agreement shall have the meanings given to them in the Agreement.

Pursuant to Section 15 of the Agreement, the Company and the Agents hereby mutually agree to amend the Agreement by deleting each reference to "$15,349,674" on the cover page of the Agreement and in Section 2(a) of the Agreement and by replacing each such reference with "$50,000,000".

This letter agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York.  Except as expressly modified by this letter agreement, the Agreement shall continue to be in full force and effect in accordance with its terms.

[Signature page follows].

If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company the enclosed duplicate of this amendment to the Agreement, whereupon this letter and your acceptance shall represent a binding agreement between the Company and the Agents in accordance with its terms.

  Very truly yours,
     
  MEDICUS PHARMA LTD.
     
  By: /s/ Raza Bokhari
    Name: Dr. Raza Bokhari
    Title: Chief Executive Officer & Executive Chairman

[Signature Page to Amendment #1 to EDA]

Confirmed as of the date first
above mentioned.

MAXIM GROUP LLC

By: /s/ Ritesh Veera                                     
Name: Ritesh Veera
Title: Co-Head of Investment Banking 


YORKVILLE SECURITIES, LLC

By:  /s/ Troy Rillo                                       
Name: Troy Rillo
Title:  Co-CEO

[Signature Page to Amendment #1 to EDA]

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer